arrow
T

Thomas D. Horvath

baylor college of medicine
H指数:26
被引数:4,574

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Commensal human gut microbes produce species specific neuroactive compounds

共生人类肠道微生物产生物种特异性神经活性化合物

2025-12-110
OAAI
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk

一项随机化1期研究,探讨莫西沙星与口服万古霉素对肠道微生物组变化的影响:对艰难梭菌风险的影响

2025-11-010
PRE
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial

粪药代动力学、微生物组及胆汁酸变化:在给予静脉注射后口服奥马环素的健康受试者中;一项I期临床试验

2025-08-010
OAAI
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study

比较ibezipolstat与万古霉素在艰难梭菌感染成人患者中的疗效、安全性、药代动力学及相关微生物组变化的疗效:一项2b期、随机、双盲、活性对照、多中心研究

2025-06-010
OAAI
Antibiofilm properties of 4-hydroxy-3-methyl-2-alkenylquinoline, a novel Burkholderia-derived alkaloid

4-羟基-3-甲基-2-烯丙基喹啉的抗生物膜特性,一种新型的伯克霍尔德菌来源的生物碱

MSPHERE
IF3.1
2025-05-270
OA
Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome
2023-05-226
OAAI